FDA Approves Bristol Myers Squibb’s New Antipsychotic Drug Cobenfy for Schizophrenia Treatment
The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride), for the treatment of…
Indian diplomacy, diaspora affairs, science, technology, policy, and business from an Indian perspective
The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride), for the treatment of…
A potential new treatment combining natural manuka honey with a widely used drug has been developed by scientists…
In a paper published in the journal of Ocular Immunology and Inflammation, physicians from the Bascom Palmer Eye…
Antiepileptic drugs may increase the risk of stroke among persons with Alzheimer’s disease, said a new study from…
A key ingredient of energy drinks could be exacerbating some of the negative effects of binge drinking, said…
A new study by University of Sydney has found that excessive use of medication increases dementia, particularly unnecessary…